http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007002667-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9880469dc8f12dad7c3ad95c6ab31fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dd3ddc8927c3110ea0a6085c3b6f80e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df664a3179873adf0037846c837fff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af33f031ec52a8789e49e24d11a00ac7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_042239340b327d298bbc9328d76d0915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bcf6b91d20af34bae0069fa89cd2a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b418bcd611b08ea0600658be94a8128c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f0fc6dcb5b14bcba6a9664a4ab12c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_239f617d8658f1fcac8163101626d7d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_938f9262ae6c4a3586645a19f8cf14e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c529a851bada03c3ce9090fc2daf3ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9daa92f5ed397e6efd9fd20543dbd5fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_121340242293bb28c411fb870625084a
publicationDate 2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007002667-A3
titleOfInvention Azaindazole compounds and methods of use
abstract Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1 -medicated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
priorityDate 2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004162282-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004082571-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID498427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2737112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412753460

Total number of triples: 49.